SCHEMBL7781706

SCHEMBL7781706

COc1ccc(S(=O)(=O)O/N=C(/C#N)c2ccc(OC)c(OC)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 9/20 0.47
PDE4B Q07343 9/20 0.47
PDE4C Q08493 9/20 0.47
PDE4D Q08499 9/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
CASP3 P42574 1/20 0.46
RAB9A P51151 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
THRB P10828 1/20 0.43
CYP2C9 P11712 1/20 0.43
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TAS2R14 Q9NYV8 1/20 0.41
TNFRSF1A P19438 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7781708 1.00 PDE4A (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4361330 0.91 ALDH1A1 (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL4361332 0.91 ALDH1A1 (0.48) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL7786880 0.89 MAPT (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL7786882 0.89 MAPT (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL7786962 0.89 NPC1 (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL7786960 0.89 NPC1 (0.47) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL5918261 0.89 EP300 (0.45) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL5918260 0.89 EP300 (0.45) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL15214878 0.86 KMT2A (0.43) ALDH1A1GAALMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US claimed
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids CIBA SPEICIALTY CHEMICALS CORP. 2001-11-01 US disclosed
US-6017675-A POLYMERIZATION CATALYST CIBA SPECIALTY CHEMIALS CORPORATION (US) 2000-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010037037-A1 Oximesulfonic acid esters and the use thereof as latent sulfonic acids QSOX1, HAO2, PAH PDE4A 4869/4885PDE4B 4881/4885PDE4C 4866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.